000 01798 a2200505 4500
005 20250518084214.0
264 0 _c20201207
008 202012s 0 0 eng d
022 _a1745-6215
024 7 _a10.1186/s13063-020-4097-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMulder, Michelle L M
245 0 0 _aComparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
_h[electronic resource]
260 _bTrials
_cFeb 2020
300 _a155 p.
_bdigital
500 _aPublication Type: Clinical Trial Protocol; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Psoriatic
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aLeflunomide
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aQuality of Life
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aVriezekolk, Johanna E
700 1 _aden Broeder, Nathan
700 1 _aMahler, Elien A M
700 1 _aHelliwell, Philip S
700 1 _avan den Hoogen, Frank H J
700 1 _aden Broeder, Alfons A
700 1 _aWenink, Mark H
773 0 _tTrials
_gvol. 21
_gno. 1
_gp. 155
856 4 0 _uhttps://doi.org/10.1186/s13063-020-4097-6
_zAvailable from publisher's website
999 _c30618469
_d30618469